Efficacy of Microcurrent Therapy After Eccentric Exercise
Launched by UNIVERSITY OF LIEGE · Dec 17, 2014
Trial Information
Current as of August 11, 2025
Completed
Keywords
ClinConnect Summary
Objective:
To study the efficacy of microcurrent to reduce DOMS (Delayed Onset Muscle Soreness) occuring after an eccentric exercise
Methods:
Experimental protocol
Participants will attend two groups of three sessions (i.e. sessions 1-2-3 and sessions 4-5-6) spaced by 3 months:
* session 1 and 4 (performed a few days before the experimental session): session for participants to get familiarized with the test battery.
* session 2 and 5: experimental session: the test battery followed by the provocative task, the test battery, the one-hour "treatment" (real microcurrents at one of the se...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Asymptomatic subjects
- Exclusion Criteria:
- • practice of sports \>3h per week
- • present pain in the lower limbs
- • history of thigh muscle injuries
- • recent injury (last 3 months) of the lower limbs
- • recent (last 3 months) plyometric exercises or lower limbs strengthening program.
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liege, , Belgium
Patients applied
Trial Officials
Christophe Demoulin, PhD
Principal Investigator
University of Liege
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials